{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:50:08Z","timestamp":1794030608970,"version":"4.8.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12072-022-10319-6","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T07:03:45Z","timestamp":1648019025000},"page":"269-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Jie Ning","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe Wen-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Yi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansel Shao Pin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren Jun Hao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hui","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Quek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yip Han","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shadab","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-4743","authenticated-orcid":false,"given":"Mark D.","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-0430","authenticated-orcid":false,"given":"Nicholas W. S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"issue":"1","key":"10319_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","volume":"49","author":"MD Muthiah","year":"2020","unstructured":"Muthiah MD, Sanyal AJ. Burden of disease due to nonalcoholic fatty liver disease. Gastroenterol Clin North Am 2020;49(1):1\u201323","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"10319_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64(1):73\u201384","journal-title":"Hepatology"},{"issue":"2","key":"10319_CR3","first-page":"3","volume":"24","author":"MD Muthiah","year":"2021","unstructured":"Muthiah MD, Cheng Han N, Sanyal AJ. A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know. Diabetes Obes Metab 2021;24(2):3\u201314","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10319_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2021;18(4):223\u2013238","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10319_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328\u2013357","journal-title":"Hepatology"},{"key":"10319_CR6","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64(6):1388\u20131402","DOI":"10.1016\/j.jhep.2015.11.004"},{"issue":"10","key":"10319_CR7","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.4254\/wjh.v7.i10.1369","volume":"7","author":"H Azzam","year":"2015","unstructured":"Azzam H, Malnick S. Non-alcoholic fatty liver disease - the heart of the matter. World J Hepatol 2015;7(10):1369\u20131376","journal-title":"World J Hepatol"},{"issue":"3","key":"10319_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355(3):260\u2013269","journal-title":"N Engl J Med"},{"issue":"4","key":"10319_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014279","volume":"9","author":"LB VanWagner","year":"2020","unstructured":"VanWagner LB, Wilcox JE, Ning H, et al. Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: The CARDIA Study. J Am Heart Assoc 2020;9(4): e014279","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10319_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12020-019-02070-0","volume":"66","author":"M Borges-Canha","year":"2019","unstructured":"Borges-Canha M, Neves JS, Lib\u00e2nio D, et al. Association between nonalcoholic fatty liver disease and cardiac function and structure\u2014a meta-analysis. Endocrine 2019;66(3):467\u2013476","journal-title":"Endocrine"},{"issue":"2","key":"10319_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.numecd.2015.10.013","volume":"26","author":"A Baragetti","year":"2016","unstructured":"Baragetti A, Pisano G, Bertelli C, et al. Subclinical atherosclerosis is associated with epicardial fat thickness and hepatic steatosis in the general population. Nutr Metab Cardiovasc Dis 2016;26(2):141\u2013153","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"10319_CR12","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.dld.2018.09.004","volume":"50","author":"K Wijarnpreecha","year":"2018","unstructured":"Wijarnpreecha K, Lou S, Panjawatanan P, et al. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis. Dig Liver Dis 2018;50(11):1166\u20131175","journal-title":"Dig Liver Dis"},{"key":"10319_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:71","journal-title":"BMJ"},{"key":"10319_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.09.021","author":"JZK Toh","year":"2021","unstructured":"Toh JZK, Pan X-H, Tay PWL, et al. A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2021. https:\/\/doi.org\/10.1016\/j.cgh.2021.09.021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"27","key":"10319_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37(27):2129\u20132200","journal-title":"Eur Heart J"},{"issue":"1","key":"10319_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/liv.14637","volume":"41","author":"PF Hsu","year":"2021","unstructured":"Hsu PF, Wang YW, Lin CC, et al. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population. Liver Int 2021;41(1):81\u201390","journal-title":"Liver Int"},{"key":"10319_CR17","doi-asserted-by":"publisher","first-page":"8820445","DOI":"10.1155\/2020\/8820445","volume":"2020","author":"YS Bae","year":"2020","unstructured":"Bae YS, Ko YS, Yun JM, Eo AY, Kim H. Association and prediction of subclinical atherosclerosis by nonalcoholic fatty liver disease in asymptomatic patients. Can J Gastroenterol Hepatol 2020;2020:8820445","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"12","key":"10319_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/GME.0000000000000503","volume":"22","author":"MK Kim","year":"2015","unstructured":"Kim MK, Ahn CW, Nam JS, Kang S, Park JS, Kim KR. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. Menopause 2015;22(12):1323\u20131327","journal-title":"Menopause"},{"issue":"1","key":"10319_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 2014;14(1):25","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"10319_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557","journal-title":"BMJ"},{"key":"10319_CR21","unstructured":"Higgins JPT GS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. In. 9.5.2 Identifying and measuring heterogeneity: The Cochrane Collaboration; 2011"},{"issue":"3","key":"10319_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","volume":"13","author":"C Tufanaru","year":"2015","unstructured":"Tufanaru C, Munn Z, Stephenson M, Aromataris E. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc 2015;13(3):196\u2013207","journal-title":"Int J Evid Based Healthc"},{"issue":"3","key":"10319_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","volume":"3","author":"Z Munn","year":"2014","unstructured":"Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014;3(3):123\u2013128","journal-title":"Int J Health Policy Manag"},{"issue":"5","key":"10319_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18087\/cardio.2021.5.n1416","volume":"61","author":"E Aksu","year":"2021","unstructured":"Aksu E, Sokmen A, Ispiroglu M, Gisi K, Celik E, Aykan AC. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. Kardiologiia 2021;61(5):51\u201358","journal-title":"Kardiologiia"},{"issue":"2","key":"10319_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5152\/akd.2014.5212","volume":"15","author":"AO Baktir","year":"2015","unstructured":"Baktir AO, \u015earli B, Emre Altekin R, et al. Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. Anatol J Cardiol 2015;15(2):137\u2013142","journal-title":"Anatol J Cardiol"},{"issue":"5","key":"10319_CR26","first-page":"457","volume":"17","author":"H Fotbolcu","year":"2010","unstructured":"Fotbolcu H, Yakar T, Duman D, et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J 2010;17(5):457\u2013463","journal-title":"Cardiol J"},{"issue":"3","key":"10319_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MEG.0000000000000008","volume":"26","author":"CY Karabay","year":"2014","unstructured":"Karabay CY, Kocabay G, Kalayci A, et al. Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study. Eur J Gastroenterol Hepatol 2014;26(3):325\u2013331","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"10319_CR28","first-page":"974","volume":"16","author":"D Oguz","year":"2016","unstructured":"Oguz D, Unal HU, Eroglu H, Gulmez O, Cevik H, Altun A. Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease. Anatol J Cardiol 2016;16(12):974\u2013979","journal-title":"Anatol J Cardiol"},{"issue":"2","key":"10319_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2014.10.004","volume":"237","author":"M Sunbul","year":"2014","unstructured":"Sunbul M, Agirbasli M, Durmus E, et al. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis 2014;237(2):490\u2013493","journal-title":"Atherosclerosis"},{"issue":"5","key":"10319_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/1755-5922.12145","volume":"33","author":"M Sunbul","year":"2015","unstructured":"Sunbul M, Kivrak T, Durmus E, et al. Nonalcoholic steatohepatitis score is an independent predictor of right ventricular dysfunction in patients with nonalcoholic fatty liver disease. Cardiovasc Ther 2015;33(5):294\u2013299","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"10319_CR31","first-page":"e46","volume":"165","author":"M Topuz","year":"2014","unstructured":"Topuz M, Dogan A, Celik A, Can C, Ozdogru I, Kemal EN. Investigation of the relationship between non-alcoholic fatty liver disease and coronary artery disease. Clin Ter 2014;165(1):e46\u201351","journal-title":"Clin Ter"},{"issue":"1","key":"10319_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2011.03.026","volume":"217","author":"Y Yilmaz","year":"2011","unstructured":"Yilmaz Y, Kurt R, Gurdal A, et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011;217(1):125\u2013129","journal-title":"Atherosclerosis"},{"issue":"5","key":"10319_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/met.2016.0132","volume":"15","author":"KI Cho","year":"2017","unstructured":"Cho KI, Jo EA, Cho SH, Kim BH. The influence of epicardial fat and nonalcoholic fatty liver disease on heart rate recovery in metabolic syndrome. Metab Syndr Relat Disord 2017;15(5):226\u2013232","journal-title":"Metab Syndr Relat Disord"},{"key":"10319_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.03.027","volume":"272","author":"GE Chung","year":"2018","unstructured":"Chung GE, Lee JH, Lee H, et al. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction. Atherosclerosis 2018;272:137\u2013144","journal-title":"Atherosclerosis"},{"issue":"6","key":"10319_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/hepr.12770","volume":"47","author":"JY Jung","year":"2017","unstructured":"Jung JY, Park SK, Ryoo JH, et al. Effect of non-alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population. Hepatol Res 2017;47(6):522\u2013532","journal-title":"Hepatol Res"},{"issue":"12","key":"10319_CR36","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","volume":"100","author":"NH Kim","year":"2014","unstructured":"Kim NH, Park J, Kim SH, et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart 2014;100(12):938\u2013943","journal-title":"Heart"},{"issue":"2","key":"10319_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4093\/dmj.2019.0001","volume":"44","author":"H Lee","year":"2020","unstructured":"Lee H, Kim G, Choi YJ, et al. Association between non-alcoholic steatohepatitis and left ventricular diastolic dysfunction in type 2 diabetes mellitus. Diabetes Metab J 2020;44(2):267\u2013276","journal-title":"Diabetes Metab J"},{"issue":"4","key":"10319_CR38","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/dom.14310","volume":"23","author":"M Lee","year":"2021","unstructured":"Lee M, Kim KJ, Chung TH, et al. Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes. Diabetes Obes Metab 2021;23(4):1041\u20131051","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10319_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","volume":"68","author":"YH Lee","year":"2018","unstructured":"Lee YH, Kim KJ, Yoo ME, et al. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. J Hepatol 2018;68(4):764\u2013772","journal-title":"J Hepatol"},{"issue":"4","key":"10319_CR40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00330-017-5075-6","volume":"28","author":"SS Brouha","year":"2018","unstructured":"Brouha SS, Nguyen P, Bettencourt R, Sirlin CB, Loomba R. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: a prospective study. Eur Radiol 2018;28(4):1345\u20131355","journal-title":"Eur Radiol"},{"issue":"10","key":"10319_CR41","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacep.2020.05.023","volume":"6","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, Cotter TG, Wazni OM, et al. Impact of nonalcoholic fatty liver disease on arrhythmia recurrence following atrial fibrillation ablation. JACC Clin Electrophysiol 2020;6(10):1278\u20131287","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10319_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/oby.20624","volume":"22","author":"G Iacobellis","year":"2014","unstructured":"Iacobellis G, Barbarini G, Letizia C, Barbaro G. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring, Md) 2014;22(2):332\u2013336","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"1","key":"10319_CR43","doi-asserted-by":"publisher","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","volume":"10","author":"A Miller","year":"2020","unstructured":"Miller A, McNamara J, Hummel SL, Konerman MC, Tincopa MA. Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction. Sci Rep 2020;10(1):12440","journal-title":"Sci Rep"},{"issue":"7","key":"10319_CR44","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/echo.14400","volume":"36","author":"W Chang","year":"2019","unstructured":"Chang W, Wang Y, Sun L, Yu D, Li Y, Li G. Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography. Echocardiography (Mount Kisco, NY) 2019;36(7):1290\u20131297","journal-title":"Echocardiography (Mount Kisco, NY)"},{"issue":"21","key":"10319_CR45","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.11569\/wcjd.v17.i21.2198","volume":"17","author":"J Huang","year":"2009","unstructured":"Huang J, Huang Q, Chen XZ, Zhou F, He JQ, Wang XL. A study of the relationship between cardiac diastolic function and liver function in patients with nonalcoholic fatty liver disease. World Chin J Digestol 2009;17(21):2198\u20132202","journal-title":"World Chin J Digestol"},{"issue":"8","key":"10319_CR46","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/jum.14536","volume":"37","author":"Q Wang","year":"2018","unstructured":"Wang Q, Ma W, Xia J. Nonalcoholic fatty liver is associated with further left ventricular abnormalities in patients with type 2 diabetes mellitus: a 3-dimensional speckle-tracking study. J Ultrasound Med 2018;37(8):1899\u20131911","journal-title":"J Ultrasound Med"},{"issue":"9","key":"10319_CR47","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1177\/0300060518782780","volume":"46","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Wang P, Guo F, et al. Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance. J Int Med Res 2018;46(9):3959\u20133969","journal-title":"J Int Med Res"},{"issue":"2","key":"10319_CR48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2337\/dc11-1820","volume":"35","author":"S Bonapace","year":"2012","unstructured":"Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012;35(2):389\u2013395","journal-title":"Diabetes Care"},{"issue":"9","key":"10319_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","volume":"19","author":"F Fallo","year":"2009","unstructured":"Fallo F, Dalla Pozza A, Sonino N, et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis 2009;19(9):646\u2013653","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"10319_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135329","volume":"10","author":"A Mantovani","year":"2015","unstructured":"Mantovani A, Pernigo M, Bergamini C, et al. Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes. PLoS One 2015;10(8): e0135329","journal-title":"PLoS ONE"},{"key":"10319_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijcard.2016.06.180","volume":"221","author":"FM Trovato","year":"2016","unstructured":"Trovato FM, Martines GF, Catalano D, Musumeci G, Pirri C, Trovato GM. Echocardiography and NAFLD (non-alcoholic fatty liver disease). Int J Cardiol 2016;221:275\u2013279","journal-title":"Int J Cardiol"},{"issue":"2","key":"10319_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/ejim.ejim_95_18","volume":"31","author":"AS Elsawaby","year":"2019","unstructured":"Elsawaby AS, Al-Fiky RA, Mohamed AE, et al. Electrocardiographic and echocardiographic changes in nonalcoholic fatty liver disease. Egypt J Internal Med 2019;31(2):191\u2013198","journal-title":"Egypt J Internal Med"},{"issue":"2","key":"10319_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/echo.14229","volume":"36","author":"RA Mahfouz","year":"2019","unstructured":"Mahfouz RA, Gouda M, Galal I, Ghareb MS. Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation. Echocardiography (Mount Kisco, NY) 2019;36(2):249\u2013256","journal-title":"Echocardiography (Mount Kisco, NY)"},{"issue":"2","key":"10319_CR54","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.19082\/1984","volume":"8","author":"A Metwaly","year":"2016","unstructured":"Metwaly A, Khalik AA, Nasr FM, Sabry AI, Gouda MF, Hassan M. Brain natriuretic peptide in liver cirrhosis and fatty liver: correlation with cardiac performance. Electron Physician 2016;8(2):1984\u20131993","journal-title":"Electron Physician"},{"issue":"2","key":"10319_CR55","doi-asserted-by":"publisher","first-page":"749","DOI":"10.13005\/bpj\/822","volume":"8","author":"M Khoshbaten","year":"2015","unstructured":"Khoshbaten M, Parkhideh S, Toufan M. Comparison of left ventricular function between patients with non-alcoholic fatty liver disease and healthy individuals. Biomed Pharmacol J 2015;8(2):749\u2013754","journal-title":"Biomed Pharmacol J"},{"issue":"5","key":"10319_CR56","first-page":"466","volume":"43","author":"M Zamirian","year":"2018","unstructured":"Zamirian M, Samiee E, Moaref A, Abtahi F, Tahamtan M. Assessment of subclinical myocardial changes in non-alcoholic fatty liver disease: A case-control study using speckle tracking echocardiography. Iran J Med Sci 2018;43(5):466\u2013472","journal-title":"Iran J Med Sci"},{"issue":"10","key":"10319_CR57","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","volume":"40","author":"S Goland","year":"2006","unstructured":"Goland S, Shimoni S, Zornitzki T, et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006;40(10):949\u2013955","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10319_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/0003319715576672","volume":"67","author":"SN Psychari","year":"2016","unstructured":"Psychari SN, Rekleiti N, Papaioannou N, et al. Epicardial fat in nonalcoholic fatty liver disease: properties and relationships with metabolic factors, cardiac structure, and cardiac function. Angiology 2016;67(1):41\u201348","journal-title":"Angiology"},{"issue":"2","key":"10319_CR59","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s11695-019-04179-7","volume":"30","author":"TB de Freitas Diniz","year":"2020","unstructured":"de Freitas Diniz TB, de Jesus RN, Jimenez LS, Pareja JC, Chaim EA, Cazzo E. Non-alcoholic fatty liver disease is associated with impairment of ejection fraction among individuals with obesity undergoing bariatric surgery: results of a cross-sectional study. Obes Surg 2020;30(2):456\u2013460","journal-title":"Obes Surg"},{"issue":"1","key":"10319_CR60","first-page":"23","volume":"47","author":"CG Moise","year":"2021","unstructured":"Moise CG, Donoiu I, Tartea G-C, Mirea O, Rogoveanu I. Assessment of left ventricular diastolic function in young adults with nonalcoholic fatty liver disease. Curr Health Sci J 2021;47(1):23\u201327","journal-title":"Curr Health Sci J"},{"issue":"1","key":"10319_CR61","first-page":"1380","volume":"21","author":"HS Sewan","year":"2021","unstructured":"Sewan HS, Aljumaily HS. Frequency of left ventricle dysfunction in non-alcoholic fatty liver disease (Nafld) patients detected by global longitudinal strain and tissue Doppler imaging in Babylon province in Iraq. Medico-Legal Update 2021;21(1):1380\u20131386","journal-title":"Medico-Legal Update"},{"issue":"8","key":"10319_CR62","doi-asserted-by":"publisher","first-page":"e017371","DOI":"10.1161\/JAHA.120.017371","volume":"10","author":"G Styczynski","year":"2021","unstructured":"Styczynski G, Kalinowski P, Michalowski L, et al. Cardiac morphology, function, and hemodynamics in patients with morbid obesity and nonalcoholic steatohepatitis. J Am Heart Assoc 2021;10(8):e017371","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10319_CR63","first-page":"20","volume":"67","author":"M Saluja","year":"2019","unstructured":"Saluja M, Kumar K, Swami YK, Meena SR, Goyal S. Association between non- alcoholic fatty liver disease and left ventricular diastolic dysfunction in patients of type 2 diabetes. J Assoc Physicians India 2019;67(8):20\u201324","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"10319_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","volume":"28","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Yki-J\u00e4rvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28(1):27\u201338","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10319_CR65","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ajg.2009.67","volume":"104","author":"LA Adams","year":"2009","unstructured":"Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009;104(4):861\u2013867","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10319_CR66","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","volume":"9","author":"ZM Younossi","year":"2011","unstructured":"Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9(6):524\u2013530","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10319_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","volume":"29","author":"NC Leite","year":"2009","unstructured":"Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009;29(1):113\u2013119","journal-title":"Liver Int"},{"issue":"3","key":"10319_CR68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.dld.2015.10.027","volume":"48","author":"S Petta","year":"2016","unstructured":"Petta S, Valenti L, Bugianesi E, Targher G, Bellentani S, Bonino F. A \u201csystems medicine\u201d approach to the study of non-alcoholic fatty liver disease. Dig Liver Dis 2016;48(3):333\u2013342","journal-title":"Dig Liver Dis"},{"issue":"43","key":"10319_CR69","doi-asserted-by":"publisher","first-page":"9488","DOI":"10.3748\/wjg.v22.i43.9488","volume":"22","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I, Milic S, Turk Wensveen T, et al. Nonalcoholic fatty liver disease\u2014a multisystem disease? World J Gastroenterol 2016;22(43):9488\u20139505","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10319_CR70","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","volume":"62","author":"S Petta","year":"2015","unstructured":"Petta S, Argano C, Colomba D, et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol 2015;62(4):928\u2013933","journal-title":"J Hepatol"},{"issue":"2","key":"10319_CR71","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/hep.26610","volume":"59","author":"L Pacifico","year":"2014","unstructured":"Pacifico L, Di Martino M, De Merulis A, et al. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology 2014;59(2):461\u2013470","journal-title":"Hepatology"},{"issue":"11","key":"10319_CR72","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jacc.2016.12.037","volume":"69","author":"SS Mitter","year":"2017","unstructured":"Mitter SS, Shah SJ, Thomas JD. A test in context: E\/A and E\/e\u2019 to assess diastolic dysfunction and LV filling pressure. J Am Coll Cardiol 2017;69(11):1451\u20131464","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10319_CR73","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/apt.16575","volume":"54","author":"SA Polyzos","year":"2021","unstructured":"Polyzos SA, Kechagias S, Tsochatzis EA. Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. Aliment Pharmacol Ther 2021;54(8):1013\u20131025","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10319_CR74","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.amjcard.2018.10.027","volume":"123","author":"JM Canada","year":"2019","unstructured":"Canada JM, Abbate A, Collen R, et al. Relation of hepatic fibrosis in nonalcoholic fatty liver disease to left ventricular diastolic function and exercise tolerance. Am J Cardiol 2019;123(3):466\u2013473","journal-title":"Am J Cardiol"},{"issue":"3","key":"10319_CR75","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jpeds.2014.11.012","volume":"166","author":"AA Sanchez","year":"2015","unstructured":"Sanchez AA, Levy PT, Sekarski TJ, et al. Markers of cardiovascular risk, insulin resistance, and ventricular dysfunction and remodeling in obese adolescents. J Pediatr 2015;166(3):660\u2013665","journal-title":"J Pediatr"},{"issue":"5","key":"10319_CR76","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1172\/JCI0213946","volume":"109","author":"DD Belke","year":"2002","unstructured":"Belke DD, Betuing S, Tuttle MJ, et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002;109(5):629\u2013639","journal-title":"J Clin Invest"},{"issue":"5","key":"10319_CR77","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jacc.2013.10.063","volume":"63","author":"SH Wan","year":"2014","unstructured":"Wan SH, Vogel MW, Chen HH. Pre-clinical diastolic dysfunction. J Am Coll Cardiol 2014;63(5):407\u2013416","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10319_CR78","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12072-019-09972-1","volume":"13","author":"B Liu","year":"2019","unstructured":"Liu B, Li Y, Li Y, et al. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis. Hep Intl 2019;13(6):757\u2013765","journal-title":"Hep Intl"},{"issue":"1 Suppl","key":"10319_CR79","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.amepre.2009.04.011","volume":"37","author":"S Dai","year":"2009","unstructured":"Dai S, Harrist RB, Rosenthal GL, Labarthe DR. Effects of body size and body fatness on left ventricular mass in children and adolescents: Project HeartBeat! Am J Prev Med 2009;37(1 Suppl):S97\u2013104","journal-title":"Am J Prev Med"},{"key":"10319_CR80","doi-asserted-by":"publisher","first-page":"105803","DOI":"10.1016\/j.cct.2019.06.017","volume":"84","author":"V Ratziu","year":"2019","unstructured":"Ratziu V, Sanyal AJ, Loomba R, et al. REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis. Contemp Clin Trials 2019;84:105803","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10319_CR81","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/hep.29724","volume":"68","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Loomba R, Rinella ME, et al. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 2018;68(1):361\u2013371","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10319-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10319-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10319-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T09:23:05Z","timestamp":1650187385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10319-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10319"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10319-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"12 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Arun J. Sanyal: Dr Sanyal is President of Sanyal Biotechnology and has stock options in Genfit, Akarna, Tiziana, Indalo, Durect and Galmed. He has served as a consultant to Astra Zeneca, Nitto Denko, Enyo, Ardelyx, Conatus, Nimbus, Amarin, Salix, Tobira, Takeda, Jannsen, Gilead, Terns, Birdrock, Merck, Valeant, Boehringer-Ingelheim, Lilly, Hemoshear, Zafgen, Novartis, Novo Nordisk, Pfizer, Exhalenz and Genfit. He has been an unpaid consultant to Intercept, Echosens, Immuron, Galectin, Fractyl, Syntlogic, Affimune, Chemomab, Zydus, Nordic Bioscience, Albireo, Prosciento, Surrozen and Bristol Myers Squibb. His institution has received grant support from Gilead, Salix, Tobira, Bristol Myers, Shire, Intercept, Merck, Astra Zeneca, Malinckrodt, Cumberland and Norvatis. He receives royalties from Elsevier and UptoDate. Mazen Noureddin: has been on the advisory board for 89BIO, Gilead, Intercept, Pfizer, Novo Nordisk, Blade, EchoSens, Fractyl, Terns, Siemens and Roche diagnostic; MN has received research support from Allergan, BMS, Gilead, Galmed, Galectin, Genfit, Conatus, Enanta, Madrigal, Novartis, Pfizer, Shire, Viking and Zydus; MN is a minor shareholder or has stocks in Anaetos, Rivus Pharma and Viking. All other authors have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}